Skip to main content
. 2022 Jul 15;2022:7698583. doi: 10.1155/2022/7698583

Table 2.

Procedure data and study endpoints.

Endpoint FRA group 105 DRA group 104 pvalue Adjusted p value®
Successful access n (%) 103 (98%) 102(98%) 0.0992
Puncture attempts mean (SD) 1.2 (±0.60) 1.9 (±1.2) <0.001 <0.001
Puncture attempts > two times 3 (2.9%) 23 (21.1%) <0.001
Puncture duration (seconds) mean (SD) 20.0 (±18.4) 56.3 (±58.3) <0.001 <0.001
Intervention (PCI) n (%) 39 (37.1%) 27 (26.0%) 0.082
Procedure duration (minutes) mean (SD) 18.2 (±15.5) 13.1 (±11.2) 0.006 0.011
Heparin dose, mg mean (SD) 7171.0 (±4818.7) 6100.9 (±2129.2) 0.047 0.172
Fluoroscopy time (minutes) mean (SD) 6.9 (±7.0) 4.4 (±4.2) 0.002 0.003
Radiation dose mean (SD) 1031.8 (±1144.1) 711.2 (±607.6) 0.014 0.063
Contrast dose mean (SD) 72.1 (±47.7) 58.0 (±36.4) 0.015 0.065
Hemostasis time in minutes mean (SD) 134.3 (±50.1) 114.8 (±44.4) 0.002 0.004
Heart rate during procedure mean (SD) 81.4 (±14.7) 78.2 (±9.8) 0.066
Systolic blood pressure during procedure mean (SD) 128 (±16) 127 (±19) 0.577
Oxygenation during placement of compression device mean (SD) 96.4 (±1.5) 96.1 (±2.9) 0.457

Chi-squared test; ∗∗ independent t-test; ® multiple linear regression model adjusted for age and undergoing PCI; FRA, forearm radial access; DRA, distal radial access; n, frequency; SD, standard deviation; PCI, percutaneous intervention.